Merrimack Pharmaceuticals, Inc. (MACK): Price and Financial Metrics


Merrimack Pharmaceuticals, Inc. (MACK): $5.25

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MACK to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

MACK Stock Price Chart Interactive Chart >

Price chart for MACK

MACK Price/Volume Stats

Current price $5.25 52-week high $7.41
Prev. close $5.25 52-week low $3.66
Day low $5.17 Volume 15,400
Day high $5.80 Avg. volume 34,970
50-day MA $5.92 Dividend yield N/A
200-day MA $5.05 Market Cap 70.40M

Merrimack Pharmaceuticals, Inc. (MACK) Company Bio


Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. The company was founded in 1993 and is based in Cambridge, Massachusetts.


MACK Latest News Stream


Event/Time News Detail
Loading, please wait...

MACK Latest Social Stream


Loading social stream, please wait...

View Full MACK Social Stream

Latest MACK News From Around the Web

Below are the latest news stories about Merrimack Pharmaceuticals Inc that investors may wish to consider to help them evaluate MACK as an investment opportunity.

Insider Buying: The Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Co-Founder & Independent Director Just Bought 63% More Shares

Even if it's not a huge purchase, we think it was good to see that Ulrik Nielsen, the Co-Founder & Independent Director...

Yahoo | January 27, 2022

Here's Why We're Not At All Concerned With Merrimack Pharmaceuticals' (NASDAQ:MACK) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Yahoo | December 6, 2021

Merrimack Reports Third Quarter 2021 Financial Results

CAMBRIDGE, Mass., November 04, 2021--Merrimack Pharmaceuticals Reports Third Quarter 2021 Financial Results

Yahoo | November 4, 2021

A Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insider increased their holdings by 43% last year

Looking at Merrimack Pharmaceuticals, Inc.'s ( NASDAQ:MACK ) insider transactions over the last year, we can see that...

Yahoo | September 6, 2021

Merrimack Reports Second Quarter 2021 Financial Results

CAMBRIDGE, Mass., August 05, 2021--Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) ("Merrimack" or the "Company") today announced its second quarter 2021 financial results for the period ended June 30, 2021.

Yahoo | August 5, 2021

Read More 'MACK' Stories Here

MACK Price Returns

1-mo -7.24%
3-mo N/A
6-mo 26.20%
1-year -17.58%
3-year -16.00%
5-year -85.17%
YTD 34.27%
2021 -43.25%
2020 118.73%
2019 -18.39%
2018 -62.34%
2017 -74.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5115 seconds.